Thomas O Dotson, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 320 W Main St, White Sulphur Springs, WV 24986 Phone: 304-536-4870 Fax: 304-536-8010 |
George R Thompson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 320 W Main St, White Sulphur Springs, WV 24986 Phone: 304-536-4870 Fax: 304-536-8010 |
Douglas L Jones, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 320 W Main St, White Sulphur Springs, WV 24986 Phone: 304-536-4870 Fax: 304-536-8010 |
Dr. Randolph Eugene Modlin, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 320 W Main St, White Sulphur Springs, WV 24986 Phone: 304-536-4870 |
William Norman Cunningham, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 320 W Main St, White Sulphur Springs, WV 24986 Phone: 304-536-4870 Fax: 304-536-1325 |
News Archive
Following reports that an 18-year-old student celebrating 'schoolies' week on Queensland's Gold Coast has been hospitalised with meningococcal disease, health officials have warned schoolies that the after-effects of drinking or drug-taking could disguise the onset of the disease.
According to Pharmaion report, "United States Telemedicine Market Opportunities, 2011 - 2021", the telemedicine market in the United States is projected to cross $ 13 billion by 2021. Growth in the market is anticipated on account of increasing healthcare costs, growing aging population, and rising incidence of chronic diseases.
A new analysis and infographic released today estimate California's exposure to high-priced Hepatitis C medications could range from hundreds of millions of dollars, even if only 5 percent of Californians infected with Hepatitis C receive treatment through state programs.
Affymax, Inc., today announced the pricing of an underwritten public offering of 8,474,576 shares of its common stock at a price to the public of $5.90 per share. The gross proceeds to Affymax from this offering are expected to be approximately $50.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
Fifteen percent to 20 percent of people worldwide suffer from migraines - excruciating headaches often presaged by dramatic sensations, or "auras." By studying a rare, inherited form of migraine, researchers at Vanderbilt University Medical Center have found clues to the biological basis of the painful, debilitating disorder.
› Verified 3 days ago